The dermaPACE Breakthrough
The dermaPACE is new medical device for wound care. It is FDA approved (U.S. Food and Drug Administration) for treating venous stasis ulcers and diabetic foot ulcers. It uses sonic shock waves to stimulate healing in a variety of different types of wounds. Additionally, the dermaPACE device is approved by many international regulators to treat chronic and acute conditions of the skin and subcutaneous soft tissues (the tissue under the skin).
The body’s physiological responses to the application of shock wave treatment has been researched for over 3 decades. It’s safety and efficacy has been well documented over those 30 years. However, several of the most clinically relevant developments regarding tissue regeneration were discovered recently. Peer-reviewed, scientific studies and the extensiveness of literature examining medical shock wave therapy is thoroughly documented. The results (both individually and collectively) paint a strong picture of the potential benefits that PACE based treatments can offer those suffering from painful wounds. While more research can undoubtedly better our understanding of the possible advantages, there already exists a vast body of compelling evidence.
View our SANUWAVE Mechanism of Action video:
Medical innovators originally designed Shockwave treatment to treat kidney stones back in the 1990’s. Over the interceding three decades, researchers and practitioners have collected a wealth of data and medical experience in the realm of Shockwave therapies. These practical lessons have been combined with advancements in engineering to produce a medical tool like none other on the market. The state-of-the-art dermaPACE device represents the gold standard in Shockwave technologies. Optimizing quality, efficacy and safety were at the heart of the development process. The dermaPACE has undergone comprehensive clinical studies and rigorous testing to confirm its safety and efficiency.
Research conducted using Doppler imaging to measure blood flow in treatment areas have demonstrated a marked increase in blood perfusion and vessel density after 24 hours since treatment. This finding is valuable because it decreases the chances of ischemia (lack of blood flow) that is so often associated with inadequate healing. It is important to note that studies have shown that patients who have undergone PACE intervention did not experience any negative vascular side effects such as an unsafe change in blood pressure.
Breaking Down Biofilm
Have you ever heard of biofilm? No it’s not a biographical movie, it’s an ultrathin, protective layer that entrenched bacterial colonies will sometimes produce. Just like our autoimmune system will defend our bodies from harmful pathogens, bacteria use the biofilm to keep out antibiotics. It creates a physical defensive barrier to protect the colony against antibiotic treatment. Shock wave therapies (like PACE) have been proven to break down the biofilm barrier, allowing antibiotics to penetrate to the bacteria and eradicate the colony.
Just as with many biological processes, there are several different pathways and stages of wound healing. One of them, is the inflammatory (or swelling) stage. While there is a misconception out there that swelling is bad and should be avoided, it is in fact a necessary step in the healing process. PACE treatment will trigger an immediate inflammatory response. You might be asking yourself, “how does that help?” Well, swelling signals the body to initiate certain actions to repair any damage in the area.
Researchers at highly respected research hospitals have discovered that PACE treatments lead to an increase of white blood cells that pass through the vessel wall, moving into the treated tissues. The leukocytes in white blood cells are central to the healing process. Increasing their flow during the inflammatory phase of wound healing triggers the release of compounds that cause the growth of new blood vessels (pro-angiogenic). Researchers have demonstrated that pro-angiogenic factors have a profound impact on healing. Shock wave treatment causes the wound to move quickly through the inflammatory phase into the proliferation (cell duplication) phase of healing.
What Should I Expect the Day of the Procedure?
You should arrive early to your doctor’s office or the treatment center; especially if this is your first treatment. Wear comfortable, loose-fitting clothing. Depending on the location of the injury and the preference of your healthcare provider, you may be asked to put on a hospital gown. The staff will quickly check your vitals (temperature, pulse and blood pressure) and ask you a few questions about your general health. Your physician may touch (palpate) around the area to determine the ideal target spot. This is the area of maximum tenderness. He or she will mark the area with a surgical marking pen. If necessary, some imaging scans may be taken. This can include an ultrasound, an x-ray or others. It is possible that the procedure may cause some minor discomfort or pain. To avoid this, local anesthesia may be administered.
A conductive gel will be applied to the skin over the target area (the area previously marked with the surgical marking pen). This high viscosity gel will promote the transference of shockwave from the instrument to the tissue. This will enhance the effectiveness of the treatment.
What Should I Expect for After the Procedure?
After the procedure, you will need to stay at the office or clinic for observation until the anesthesia wears off. Once you can safely move around, you will be permitted to leave. The staff will cover post-operative instructions from your physician. It is a good idea to get these in writing because following them to the best of your ability is important for a full and speedy recovery.
Are There Possible Side Effects or Complications?
The use of orthoPACE is a non-invasive procedure and presents minimal risks. In rare instances, it may lead to temporary cases of red skin, bruising, numbness or tingling. There may be a temporary increase in pain immediately after the procedure. Some individuals report that the pain returns after the procedure. This pain may be constant or the episodes may come and go. This can persist for a few days to several weeks. It is also typical to experience some discomfort after engaging in intense exercise. These side effects are generally mild and go away on their own after a few days. If they do not, contact your healthcare professional.
PRP for Wound Care
The body is a living, breathing system that’s designed to self-regulate, or keep itself in good working order. Modern medical science offers many seemingly miraculous Wound Care treatments, but it’s ultimately the body which must heal itself. Platelet Rich Plasma (PRP) therapy is a newer medical therapy which triggers a powerful healing response in injured tissue.
This makes it incredibly useful for a wide variety of Wound Care and chronic musculoskeletal conditions. Stubborn joint and back problems years in the making often respond well. It can also be effective at speeding up the healing of newer (acute) injuries and ulcerations. Not surprisingly, this makes it highly popular among athletes at all performance levels.
The development of PRP therapy comes at a fortunate time, as is indicated by decades of research. This nation is known for its concerted, society-level effort to advance medical science and its pro-research, pro-technology attitudes. Years of accumulated studies indicates that about 4 in 100 are suffering from a moderate-severe chronic sports injury at any time. An additional estimated 15% of adults over 40 experience moderate-severe Lower Back Pain (LBP).
The approximate financial cost of this LBP alone is a staggering $12.9 billion and wound care doubles that, yet this only takes into account payments for various Long Term Disability programs. The actual figure is likely in the 100s of billions. It is further stated that, as the population ages, the incidence of all chronic musculoskeletal conditions will increase dramatically.
Regenerative Medicine treatments such as PRP can be used to effectively treat both acute wou and chronic injuries. This includes treatment-resistant conditions like the back pain mentioned above, achilles tendonitis, rotator cuff injuries, chronically sprained ankles, and plantar fasciitis. Our current understanding of the nature of chronic injuries at the cellular level is expanding rapidly. As this continues to happen regenerative treatments such as PRP are expected to play a much larger role in wound care and musculoskeletal medicine.